Effects of berberine hydrochloride on methamphetamine-induced anxiety behaviors and relapse in rats

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 384

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-23-11_015

تاریخ نمایه سازی: 19 دی 1399

Abstract:

Objective(s): This research aimed at evaluating the effect of berberine hydrochloride on anxiety-related behaviors induced by methamphetamine (METH) in rats, assessing relapse and neuroprotective effects. Materials and Methods: 27 male Wistar rats were randomly assigned into groups of Control, METH-withdrawal (METH addiction and subsequent withdrawal), and METH addiction with berberine hydrochloride oral treatment (100 mg/kg/per day) during the three weeks of withdrawal. Two groups received inhaled METH self-administration for two weeks (up to 10 mg/kg). The elevated plus maze (EPM) test and open field test (OFT) were carried out one day after the last berberine treatment and relapse was assessed by conditional place preference (CPP) test. TUNEL assay and immunofluorescence staining for NF-κB, TLR4, Sirt1, and α-actin expression in the hippocampus were tested. Results: After 3 weeks withdrawal, berberine hydrochloride decreased locomotor activity and reduced anxiety-related behaviors in comparison with the METH-withdrawal group (p <0.001). The obtained results from CPP showed that berberine significantly reduced relapse (p <0.01). Significantly decrease in activation of TLR4, Sirt1, and α-actin in METH-withdrawal group was found and the percentage of TLR4, Sirt1, and α-actin improved in berberine-treated group (p <0.001). A significant activity rise of NF-κB of cells in the METH-withdrawal group was detected compared to berberine-treated and control groups (p <0.001). Conclusion: Treatment with berberine hydrochloride via modulating neuroinflammation may be considered as a potential new medication for the treatment of METH addiction and relapse. The histological assays supported the neuroprotective effects of berberine in the hippocampus.

Authors

Leila Rezaeian

Department of Addiction Studies, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

Hamid Kalalian Moghadam

Addiction Research Center, Shahroud University of Medical Sciences, Shahroud, Iran

Fahimeh Mohseni

Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

Mehdi Khaksari

Department of Physiology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

Raheleh Rafaiee

Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Yasaei R, Saadabadi A. Methamphetamine.  StatPearls [Internet]: StatPearls Publishing; ...
  • 2. Moratalla R, Khairnar A, Simola N, Granado N, García-Montes ...
  • 3. Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of ...
  • 4. Bannerman D, Rawlins J, McHugh S, Deacon R, Yee ...
  • 5. Felger JC. Imaging the role of inflammation in mood ...
  • 6. Coelho-Santos V, Leitao RA, Cardoso FL, Palmela I, Rito ...
  • 7. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman ...
  • 8. Femenia T, Qian Y, Arentsen T, Forssberg H, Heijtz ...
  • 9. Kawamoto EM, Cutler RG, Rothman SM, Mattson MP, Camandola ...
  • 10. Guerri C, Pascual M. Role of toll-like receptor 4 ...
  • 11. Trotta T, Porro C, Calvello R, Panaro MA. Biological ...
  • 12. Walter S, Letiembre M, Liu Y, Heine H, Penke ...
  • 13. Wang X, Northcutt AL, Cochran TA, Zhang X, Fabisiak ...
  • 14. Chong ZZ, Shang YC, Wang S, Maiese K. SIRT1: ...
  • 15. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi ...
  • 16. Calvanese V, Lara E, Suárez-Álvarez B, Dawud RA, Vázquez-Chantada ...
  • 17. Gonfloni S, Iannizzotto V, Maiani E, Bellusci G, Ciccone ...
  • 18. Shoba B, Lwin ZM, Ling LS, Bay BH, Yip ...
  • 19. Lamprecht R. The roles of the actin cytoskeleton in ...
  • 20. Young EJ, Briggs SB, Miller CA. The actin cytoskeleton ...
  • 21. Zou K, Li Z, Zhang Y, Zhang H-y, Li ...
  • 22. Sun Y, Xun K, Wang Y, Chen X. A ...
  • 23. Peng L, Kang S, Yin Z, Jia R, Song ...
  • 24. Peng W-H, Wu C-R, Chen C-S, Chen C-F, Leu ...
  • 25. Mangrulkar SV, Selote RD, Chaple DR, Chourasia A. Antiamnesic ...
  • 26. Yoo J-H, Yang E-M, Cho J-H, Lee J-H, Jeong ...
  • 27. Kulkarni S, Dhir A. Berberine: A plant alkaloid with ...
  • 28. Kulkarni SK, Dhir A. On the mechanism of antidepressant-like ...
  • 29. Fan J, Zhang K, Jin Y, Li B, Gao ...
  • 30. Shi M, Zhao C, Ge X, Yang H, Ge ...
  • 31. Chandirasegaran G, Elanchezhiyan C, Ghosh K, Sethupathy S. Berberine ...
  • 32. Karila L, Weinstein A, Aubin H-J, Benyamina A, Reynaud ...
  • 33. Moghaddam HK, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi ...
  • 34. Rafaiee R, Ahmadiankia N, Mousavi SA, Rezaeian L, Niroumand ...
  • 35. Belovicova K, Bogi E, Csatlosova K, Dubovicky M. Animal ...
  • 36. Walf AA, Frye CA. The use of the elevated ...
  • 37. Wellington D, Mikaelian I, Singer L. Comparison of ketamine–xylazine ...
  • 38. Gage GJ, Kipke DR, Shain W. Whole animal perfusion ...
  • 39. Yu S, Zhu L, Shen Q, Bai X, Di ...
  • 40. Zuloaga D, Jacobskind J, Raber J. Methamphetamine and the ...
  • 41. Zhou X-Q, Zeng X, Kong H, Sun X-L. Neuroprotective ...
  • 42. Durairajan SSK, Liu L-F, Lu J-H, Chen L-L, Yuan ...
  • 43. Moneim AEA. The neuroprotective effect of berberine in mercury-induced ...
  • 44. Jiang W, Li S, Li X. Therapeutic potential of ...
  • 45. Azam S, Jakaria M, Kim I-S, Kim J, Haque ...
  • 46. He X-F, Zhang L, Zhang C-H, Zhao C-R, Li ...
  • 47. Zhu L, Han J, Yuan R, Xue L, Pang ...
  • 48. Li  X, Wu F, Xue L, Wang B, Li ...
  • 49. Kuo C-L, Chi C-W, Liu T-Y. The anti-inflammatory potential ...
  • 50. Lee D-U, Kang YJ, Park MK, Lee YS, Seo ...
  • 51. Chen F, Yang Z, Liu Y, Li L, Liang ...
  • 52. Yu L, Li Q, Yu B, Yang Y, Jin ...
  • 53.Chen D-L, Yang K-Y. Berberine Alleviates Oxidative Stress in Islets ...
  • 54. Li H-Y, Wang X-C, Xu Y-M, Luo N-C, Luo ...
  • 55. Zhu X, Guo X, Mao G, Gao Z, Wang ...
  • of berberine against hydrogen peroxide‐induced apoptosis by upregulation of sirtuin ...
  • 56. Cheng Y, Takeuchi H, Sonobe Y, Jin S, Wang ...
  • 57. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi ...
  • 58. Codocedo JF, Allard C, Godoy JA, Varela-Nallar L, Inestrosa ...
  • 59. Paraíso AF, Mendes KL, Santos SHS. Brain activation of ...
  • 60. Haase R, Kirschning CJ, Sing A, Schrottner P, Fukase ...
  • نمایش کامل مراجع